Medication and supplement use for managing joint symptoms among patients with knee and hip osteoarthritis: A cross-sectional study

BMC Musculoskeletal Disorders

Volumn 13, Issue , 2012, Pages

  Driban, Jeffrey B ^a   Boehret, Sara A ^b   Balasubramanian, Easwaran ^c   Cattano, Nicole M ^d   Glutting, Joseph ^e   Sitler, Michael R ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WEST CHESTER UNIVERSITY   (United States)

^e UNIVERSITY OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; GLUCOSAMINE; HYDROMORPHONE; IBUPROFEN; INDOMETACIN; MELOXICAM; NAPROXEN; NON PRESCRIPTION DRUG; OXYCODONE; PARACETAMOL; TRAMADOL; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BEHAVIOR; CROSS-SECTIONAL STUDY; FEMALE; HIP OSTEOARTHRITIS; HIP RADIOGRAPHY; HUMAN; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUTRIENT SUPPLY; OUTPATIENT CARE; PATIENT CARE; PATIENT COMPLIANCE; SELF REPORT; SYMPTOM; AGED; ATTITUDE TO HEALTH; DIET SUPPLEMENTATION; DRUG COMBINATION; DRUG EFFECT; HEALTH; HIP; INTERVIEW; KNEE; MIDDLE AGED; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY; PATIENT EDUCATION; PATIENT SATISFACTION; PRESCRIPTION; QUESTIONNAIRE; RISK; SELF MEDICATION; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UNITED STATES;

AGED; ANALGESICS; ANTI-INFLAMMATORY AGENTS; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIP JOINT; HUMANS; INTERVIEWS AS TOPIC; KNEE JOINT; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NONPRESCRIPTION DRUGS; ODDS RATIO; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; OUTPATIENT CLINICS, HOSPITAL; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; PHILADELPHIA; QUESTIONNAIRES; SELF MEDICATION; TIME FACTORS; TREATMENT OUTCOME; URBAN HEALTH;

EID: 84858966801     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-13-47     Document Type: Article

References (15)

1. OARSI-FDA initiative: defining the disease state of osteoarthritis. Lane NE, Brandt K, Hawker G, Peeva E, Schreyer E, Tsuji W, Hochberg MC, Osteoarthr Cartil 2011 19 478 482 10.1016/j.joca.2010.09.013 21396464
2. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, et al. Osteoarthr Cartil 2008 16 137 162 10.1016/j.joca.2007.12. 013 18279766 (Pubitemid 351222155)
3. Self-care and professionally guided care in osteoarthritis: racial differences in a population-based sample. Albert SM, Musa D, Kwoh CK, Hanlon JT, Silverman M, J Aging Health 2008 20 198 216 18287328 (Pubitemid 351238284)
4. Managing osteoarthritis. Medication use among seniors in the community. Lawson B, Putnam W, Nicol K, Archibald G, Mackillop J, Conter H, Frail D, Can Fam Physician 2004 50 1664 1670 15648382 (Pubitemid 40011947)
5. Self management of chronic disease by older adults: a review and questions for research. Clark NM, Becker MH, Janz NK, Lorig K, Rakowski W, Anderson L, J Aging Health 1991 3 3 10.1177/089826439100300101
6. Association of health-related quality of life with dual use of prescription and over-The-counter nonsteroidal antiinflammatory drugs. Kovac SH, Saag KG, Curtis JR, Allison J, Arthritis Rheum 2008 59 227 233 10.1002/art.23336 18240185 (Pubitemid 351272959)
7. The burden of chronic disease: the future is prevention. Introduction to Dr. James Marks' presentation, "The Burden of Chronic Disease and the Future of Public Health". Hardy GE Jr, Prev Chronic Dis 2004 1 04 15670435
8. Patterns of use and public perception of over-The-counter pain relievers: focus on nonsteroidal antiinflammatory drugs. Wilcox CM, Cryer B, Triadafilopoulos G, JRheumatol 2005 32 2218 2224 (Pubitemid 41587871)
9. Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project. Jordan JM, Luta G, Stabler T, Renner JB, Dragomir AD, Vilim V, Hochberg MC, Helmick CG, Kraus VB, Arthritis Rheum 2003 48 675 681 10.1002/art.10822 12632420 (Pubitemid 36302003)
10. Diagnostic Utility Statistics [Computer software]. Watkins MW, Phoenix, AZ: Ed & Psych Associates 2010
11. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000 43 1905 1915 11014340
12. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, et al. AnnRheum Dis 2003 62 1145 1155 10.1136/ard.2003.011742 (Pubitemid 37500619)
13. Guideline on the treatment of osteoarthritis (OA) of the knee. http://www.aaos.org/research/guidelines/OAKrecommendations.pdf
14. The care and management of osteoarthritis in adults. http://www.nice.org. uk/nicemedia/live/11926/39557/39557.pdf
15. A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain. Doherty M, Hawkey C, Goulder M, Gibb I, Hill N, Aspley S, Reader S, Ann Rheum Dis 2011 70 1534 1541 10.1136/ard.2011.154047 21804100